Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

BTAI

BioXcel Therapeutics (BTAI)

BioXcel Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BTAI
DatumZeitQuelleÜberschriftSymbolFirma
29/01/202522h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
21/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BTAIBioXcel Therapeutics Inc
16/01/202514h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
11/01/202502h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
11/01/202502h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
10/01/202522h45Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BTAIBioXcel Therapeutics Inc
08/01/202513h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
30/12/202422h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BTAIBioXcel Therapeutics Inc
18/12/202423h16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BTAIBioXcel Therapeutics Inc
18/12/202400h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
18/12/202400h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
18/12/202400h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
16/12/202421h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
16/12/202421h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
16/12/202420h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
25/11/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
25/11/202412h00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BTAIBioXcel Therapeutics Inc
22/11/202414h16GlobeNewswire Inc.BioXcel Therapeutics Announces Pricing of $7.0 Million Public OfferingNASDAQ:BTAIBioXcel Therapeutics Inc
21/11/202422h47GlobeNewswire Inc.BioXcel Therapeutics Announces Proposed Public OfferingNASDAQ:BTAIBioXcel Therapeutics Inc
21/11/202422h46Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BTAIBioXcel Therapeutics Inc
21/11/202422h43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
14/11/202415h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BTAIBioXcel Therapeutics Inc
14/11/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
14/11/202413h00GlobeNewswire Inc.BioXcel Therapeutics Reports Third Quarter 2024 Financial ResultsNASDAQ:BTAIBioXcel Therapeutics Inc
12/11/202413h00GlobeNewswire Inc.BioXcel Therapeutics Advances Pivotal Phase 3 Trials of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders, Schizophrenia, and Alzheimer’s DementiaNASDAQ:BTAIBioXcel Therapeutics Inc
08/11/202413h00GlobeNewswire Inc.BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024NASDAQ:BTAIBioXcel Therapeutics Inc
29/10/202412h00GlobeNewswire Inc.BioXcel Therapeutics to Present at ThinkEquity ConferenceNASDAQ:BTAIBioXcel Therapeutics Inc
15/10/202413h00GlobeNewswire Inc.BioXcel Therapeutics Announces U.S. Department of Defense Grant to University of North Carolina to Fund Study of BXCL501 (Sublingual Dexmedetomidine) for Treating Acute Stress DisorderNASDAQ:BTAIBioXcel Therapeutics Inc
09/10/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
04/10/202403h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BTAI